Datasheet | December 2, 2022

Overcome Lack Of Robust B Cell Markers Using Opto's AbD Workflow

Source: Berkeley Lights
T cell cancer research iStock-981878366

Opto® Memory B Discovery on the Beacon® Optofluidic System enables rapid selection of lead molecules by function-forward screening of B cells from immunized animals in under 1 week. While Opto® Plasma B Discovery workflows enable screening of mouse plasma B cells, the Opto Memory B Discovery workflow enables rapid screening of rabbit memory B cells. Rabbits have unique gene diversification strategies that produce antibodies with high affinity and specificity, making rabbit antibodies uniquely valuable reagents for basic research, diagnostics, and therapeutic development. Rabbit polyclonal antibodies are widely used for research applications; however, monoclonal antibodies are often preferred for diagnostic and therapeutic applications due to their well-defined specificity and stability.

Single B cell approaches are an attractive approach for the discovery of rabbit monoclonal antibodies as compared with hybridoma and phage display owing to the low fusion efficiency and loss of cognate heavy/light chain pairing in the latter two approaches, respectively. A central challenge to single B cell screening in rabbits is the lack of robust B cell markers that enable the purification of rabbit plasma B cells. As a result, rabbit B cell screening approaches are typically performed using memory B cells that must be activated to secrete antibodies for screening purposes.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene